Clinical trial
A Prospective Non-interventional Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
NCT05440487 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Non-interventional Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 15, 2015
- Completion date
- October 29, 2021
- Enrollment
- 489 (actual)
- Sites
- 102
Conditions
As the registry lists them; a condition with its own page is linked.
chronic iron overload